A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Pheast Therapeutics
Theolytics Limited
University of Colorado, Denver
NiKang Therapeutics, Inc.
Dana-Farber Cancer Institute
EMD Serono
Regor Pharmaceuticals Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Oncoinvent Solutions AS
National Cancer Institute (NCI)
BioNTech SE
MOMA Therapeutics
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Chong Kun Dang Pharmaceutical
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mersana Therapeutics
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
Revolution Medicines, Inc.
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Masonic Cancer Center, University of Minnesota
AstraZeneca
Arcus Biosciences, Inc.
Nerviano Medical Sciences
Boehringer Ingelheim
Agenus Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.